Joshua Lederberg
Corporate Officer/Principal chez The Rockefeller University
Profil
Dr. Lederberg is currently University Professor-Emeritus at The Rockefeller University, having previously served as its President.
His awards and recognitions include the National Academy of Sciences, Royal Society of London, US Medal of Science, and many more.
He has published extensively on infectious disease and biowarfare defense, and serves on the Defense Science Board and the DTRA Advisory Council.
Dr. Lederberg received his PhD from Yale University in microbiology.
Dr. Lederberg was awarded the Nobel Prize in Medicine for studies on the organization of the genetic material in bacteria.
Postes actifs de Joshua Lederberg
| Sociétés | Poste | Début |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
Anciens postes connus de Joshua Lederberg
| Sociétés | Poste | Fin |
|---|---|---|
| The Rockefeller University | President | - |
Paladin Capital Group
 Paladin Capital Group Investment ManagersFinance Paladin Capital Group (Paladin Capital) is a private equity subsidiary of Penn Ave Investments LLC founded by Mark Maloney and Michael Steed in 2001. The firm is headquartered in Washington, DC with offices in New York City, Silicon Valley, London and Luxembourg. | Private Equity Investor | - |
Formation de Joshua Lederberg
| Yale University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Paladin Capital Group
Paladin Capital Group Investment ManagersFinance Paladin Capital Group (Paladin Capital) is a private equity subsidiary of Penn Ave Investments LLC founded by Mark Maloney and Michael Steed in 2001. The firm is headquartered in Washington, DC with offices in New York City, Silicon Valley, London and Luxembourg. | Finance |